Rinvoq ER 15 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FS23W
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $54,260
Award facts
- Contract value 100% obligated
- $54,260.47 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $54.3K delivery order to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of RINVOQ ER 15 mg tablets (30-count units). This is a firm fixed-price, non-set-aside contract with performance in Conshohocken, Pennsylvania and an ultimate completion date of January 7, 2026. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999.9M vehicle valued through December 2031 that serves as the primary procurement vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is a critical federal vendor supplying a comprehensive range of medications, vaccines, medical devices, and specialized healthcare commodities to military and veteran healthcare systems. The company competes on a full and open basis for federal procurements and demonstrates extensive capability in fulfilling government orders for essential pharmaceutical commodities across multiple therapeutic domains. This particular task order for RINVOQ, a specialty pharmaceutical used in the treatment of inflammatory conditions, reflects the company's ongoing role in supporting the Defense Health Agency and other federal medical institutions through its established IDC vehicle.
Quick answers
Who was awarded contract SPE2DR26FS23W?
SPE2DR26FS23W was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FS23W worth?
The government has obligated $54,260 on SPE2DR26FS23W.
Is contract SPE2DR26FS23W an order under another contract?
Yes. SPE2DR26FS23W is a delivery order under SPE2DR25D2204, an indefinite delivery contract.
Was contract SPE2DR26FS23W competed?
The extent of competition for SPE2DR26FS23W was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award